NCT06317207

Brief Summary

To evaluate the safety of reoperation in patients with renal tumors who have ipsilateral tumor recurrence after nephron-sparing partial nephrectomy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
11 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

11 years

First QC Date

March 9, 2024

Last Update Submit

March 15, 2024

Conditions

Renal Cell CarcinomaRobotic Surgical Procedures

Outcome Measures

Primary Outcomes (1)

  • Operation time

    Operation time

    1 week

Secondary Outcomes (1)

  • Estimated blood loss

    1 week

Study Arms (1)

observation group

patients who underwent reoperation for locally rRCC after pNSS

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We collected the patients who underwent reoperation for locally rRCC after pNSS in our institution from 2013 to 2023.

You may qualify if:

  • \. ipsilateral local rRCC (any recurrence in the ipsilateral kidney and retroperitoneum)

You may not qualify if:

  • With distant metastasis;
  • Lacking essential sugery information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsKidney NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

March 9, 2024

First Posted

March 19, 2024

Study Start

January 1, 2013

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

All the information we will provide with the publication